As a well-studied E3 ligase in cancer biology, FBXW7 was recently reported to be involved in lipid and glucose metabolism via the degradation of Fetuin-A or REV-ERBα in the liver (Zhao et al, 2018; Zhao et al, 2016). Here, FBXW7 is linked to cancer.